Manufacturers’ Group Is Not Satisfied With FDA In-Vitro Diagnostics Office

Diagnostic manufacturers have not seen the improved review times they expected from the founding of the Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) in 2002, according to the chief counsel for the Association of Medical Diagnostic Manufacturers (AMDM)

More from Archive

More from Medtech Insight